NCT05033808View on ClinicalTrials.gov

Epirubicin for the Treatment of Sepsis & Septic Shock

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Sepsis
Interventions
DRUG

Epirubicin

Epirubicin is given once over 15 Minutes via a central line

DRUG

Placebo

NaCl is given once over 15 Minutes via a central line

Trial Locations (5)

17489

NOT_YET_RECRUITING

University Medicine Greifswald, Greifswald

20251

NOT_YET_RECRUITING

Universitätsklinikum Hamburg Eppendorf, Hamburg

44892

NOT_YET_RECRUITING

University Hospital Knappschafstkrankenhaus Bochum, Bochum

97080

NOT_YET_RECRUITING

Universitätsklinikum Würzburg, Würzburg

07747

RECRUITING

Jena University Hospital, Jena

All Listed Sponsors
collaborator

Ruhr University of Bochum

OTHER

collaborator

University Medicine Greifswald

OTHER

lead

Jena University Hospital

OTHER